Clinical Trial Update: Study of the Human Anti-TNF Monoclonal Antibody in Patients With Active Rheumatoid Arthritis

View source ↗

Summary

Abbott announced marketing approval for a human anti-TNF monoclonal antibody for active rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Abbott | Conditions: Rheumatoid Arthritis | Status: APPROVED_FOR_MARKETING